CTC
QLTY icon

Central Trust Company’s GMO US Quality ETF QLTY Stock Holding History

Central Trust Company’s Portfolio QLTY Stock Details QLTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.7M Buy
820,980
+215,930
+36% +$8.28M 0.58% 35
2025
Q4 		$23.3M Buy
605,050
+154,897
+34% +$5.82M 0.46% 45
2025
Q3 		$16.3M Buy
450,153
+447,706
+18,296% +$15.6M 0.34% 57
2025
Q2 		$83.8K Sell
2,447
-294
-11% -$9.32K ﹤0.01% 704
2025
Q1 		$85.7K Sell
2,741
-8,506
-76% -$278K ﹤0.01% 691
2024
Q4 		$360K Buy
+11,247
New +$366K 0.01% 466

Other funds holding QLTY

AG
AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
LA
Legacy Advisors Plymouth Meeting, Pennsylvania $848M AUM 21.32% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

Central Trust Company's QLTY Position: Q1 2026 in Review

Central Trust Company increased its GMO US Quality ETF (QLTY) stake by 36% in Q1 2026, buying an estimated $8.28M and bringing the position to 820,980 shares worth $29.7M. The position accounts for 0.58% of the portfolio, ranked #35.

Central Trust Company first reported a position in QLTY in Q4 2024 and has held it in 6 quarters since. 149 funds tracked by Wall St. Rank hold QLTY as of Q1 2026.

  • Central Trust Company held 820,980 shares of GMO US Quality ETF worth $29.7M as of Q1 2026.
  • Central Trust Company bought 215,930 GMO US Quality ETF shares in Q1 2026, an estimated $8.28M.
  • GMO US Quality ETF made up 0.58% of Central Trust Company's portfolio in Q1 2026, its #35 holding.
  • Central Trust Company first reported a position in GMO US Quality ETF in Q4 2024 and has held it in 6 quarters since.
  • 149 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.